SurModics Correlations
SRDX Stock | USD 30.21 0.41 1.34% |
The current 90-days correlation between SurModics and Neuropace is 0.11 (i.e., Average diversification). The correlation of SurModics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SurModics Correlation With Market
Significant diversification
The correlation between SurModics and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SurModics and DJI in the same portfolio, assuming nothing else is changed.
SurModics | Build AI portfolio with SurModics Stock |
Moving together with SurModics Stock
Moving against SurModics Stock
0.45 | CI | Cigna Corp | PairCorr |
0.56 | EKSO | Ekso Bionics Holdings | PairCorr |
0.55 | ELMD | Electromed | PairCorr |
0.53 | MSPRZ | MSP Recovery Symbol Change | PairCorr |
0.51 | EMBC | Embecta Corp | PairCorr |
0.46 | EDAP | EDAP TMS SA | PairCorr |
0.43 | MSPRW | MSP Recovery Symbol Change | PairCorr |
0.62 | MODD | Modular Medical | PairCorr |
0.6 | MNDR | Mobile health Network | PairCorr |
0.57 | MLSS | Milestone Scientific | PairCorr |
0.52 | NXLIW | Nexalin Technology | PairCorr |
0.5 | NAOV | NanoVibronix | PairCorr |
0.31 | MXCT | MaxCyte | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SurModics Stock performing well and SurModics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SurModics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NPCE | 3.11 | (0.11) | 0.00 | (20.60) | 0.00 | 5.22 | 48.86 | |||
CVRX | 4.29 | 0.32 | 0.06 | 0.29 | 7.34 | 11.74 | 50.43 | |||
OFIX | 1.78 | (0.53) | 0.00 | (0.23) | 0.00 | 3.87 | 14.80 | |||
AORT | 1.46 | 0.40 | 0.22 | 1.43 | 1.03 | 3.50 | 18.73 | |||
ANGO | 2.17 | (0.31) | 0.00 | (0.11) | 0.00 | 5.05 | 23.06 | |||
MMSI | 1.17 | (0.27) | 0.00 | (0.21) | 0.00 | 2.53 | 14.94 | |||
CNMD | 1.99 | (0.26) | 0.00 | (0.04) | 0.00 | 3.82 | 20.87 | |||
ICUI | 1.68 | (0.32) | 0.00 | (0.19) | 0.00 | 3.69 | 11.56 |
SurModics Corporate Management
Charles Olson | Sr. VP and General Manager of Medical Device | Profile | |
Timothy Arens | VP of Corporate Devel. and Strategy | Profile | |
Joseph Stich | VP and General Manager of In-Vitro Diagnostics | Profile | |
Gordon JD | General Legal | Profile | |
Gordon Weber | General Legal | Profile |